Physician

Peter J. Coutlakis, M.D.

According to 2025 Medicare claims, Peter Coutlakis, M.D. (NPI: 1528064482) practices rheumatology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is ARTHRITIS SPECIALISTS, LTD. (NPI: 1710983580; TIN: 541968161) and primary practice location at 23235-4730.

Coutlakis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 449 traditional Medicare patients, billed 215,542 HCPCS/CPT codes, and received $2,056,025 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,494 prescription claims across 281 beneficiaries totaling $169,138 in drug costs, led by Celecoxib (Celecoxib). Open Payments data shows 88 records totaling $1,877. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $255,859 and ending at $169,138. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	417	91,197	$1,483,333
2016	456	87,093	$1,764,406
2017	423	106,491	$1,773,393
2018	392	118,190	$1,822,354
2019	374	85,702	$1,400,326
2020	389	145,149	$2,060,515
2021	401	175,483	$2,090,043
2022	430	188,243	$1,969,151
2023	445	215,120	$2,354,869
2024	449	215,542	$2,056,025

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	1,761	$255,859
2016	238	1,621	$167,731
2017	218	1,674	$163,555
2018	224	1,718	$260,393
2019	193	1,144	$129,279
2020	219	1,468	$225,292
2021	252	1,535	$366,906
2022	275	1,436	$306,989
2023	261	1,395	$202,896
2024	281	1,494	$169,138

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	112	590	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	351	732	$86
36415	Insertion of needle into vein for collection of blood sample	100	360	$3
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	72	465	$1
J7050	Infusion, normal saline solution, 250 cc	110	582	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	106	5,576	$4,600
Methotrexate	Methotrexate Sodium	102	7,251	$3,962
Mycophenolate Mofetil	Mycophenolate Mofetil	24	1,460	$3,952
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	4,180	$3,739
Pregabalin	Pregabalin	19	1,410	$2,653

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$1,877	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter J. Coutlakis, M.D.?

Tedicare shows public-source Medicare data for Peter J. Coutlakis, M.D. (NPI 1528064482), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter J. Coutlakis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter J. Coutlakis, M.D.?

Peter J. Coutlakis, M.D. is linked to ARTHRITIS SPECIALISTS, LTD. (billing NPI 1710983580) in the available physician profile data.

Does Peter J. Coutlakis, M.D. have Open Payments data?

Peter J. Coutlakis, M.D. has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.